The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Morgan Bradley Paul since year 2005.
The trader's CIK number is 1659025.
At the time of this reporting, Morgan Bradley Paul is the SVP Drug Discovery & Early Dev of Cytokinetics Inc .
(stock ticker symbol CYTK).
See this page for all insider trading activities at Cytokinetics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-08-31||CYTK||Cytokinetics Inc||Option Ex||118,330||8.65||1,023,436|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Morgan Bradley Paul (SVP Drug Discovery & Early Dev of Cytokinetics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.